ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
Orum Therapeutics
A Scientist at Orum Therapeutics leads the Bioanalytical and PK/PD function, focusing on the characterization of Antibody-Drug Conjugates (ADCs). The role involves managing bioanalytical strategies, overseeing ADME studies, and ensuring high-quality data generation in GLP/GCP environments.
Headquarters
Lexington, Massachusetts, United States
Company Size
11-50 employees
Founded
2016
Orum Therapeutics is a biotechnology company developing cell‑specific, targeted protein degraders that combine the selectivity of antibody targeting with the mechanism of targeted protein degradation. Their platform aims to selectively eliminate disease‑relevant proteins in defined cell types, expanding the druggable proteome while improving therapeutic precision and safety. Orum advances proprietary degrader therapeutics and works with partners to translate its technology into new treatments.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Orum Therapeutics.
Orum Therapeutics didn’t post a salary, so this is our estimate from similar listings.
Senior Research Scientist – Pharmacokinetics
AbCellera
Senior Principal Scientist | Antibody-siRNA Bioanalytical & Biodistribution
lifelancer
Senior Principal Scientist | Antibody-siRNA Bioanalytical & Biodistribution
lifelancer
Scientific Advisor - ADME Project Leadership for Biologics
Eli Lilly and Company
Director, Oncology Bioanalytical Strategy Lead
AstraZeneca
Scientist/Senior Scientist
ASTARPRD